PROTOPAPAS ANNA (President & CEO) received a stock award from MERSANA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/13/2023ACC: 0001104659-23-100443
DirectorOfficer· President & CEO
Since Jan 2019
+33.29K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.29K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.64K
Price / share
—
Trade value
—
% of position
32.7%
9/11/2023
50.95K→67.59K
Total
Net shares
+16.64K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2023 | A · Award | +16.64K | — | — | 32.7% | 50.95K | 67.59K |
| Total | +16.64K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
16.64K shares
Shares
+16.64K
Strike price
1.32
Held after
16.64K
Exercisable
—
9/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock16.64K shares | 9/11/2023 | A · Award | +16.64K | 1.32 | — | 16.64K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned240.24K
Common Stock
IndirectShares owned72.26K
Total
312.51K indirect312.51K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 240.24K | Indirect |
| Common Stock | 72.26K | Indirect |
| Total | 312.51K | 312.51K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported